CarsonAllaria Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Buy
13,244
+143
+1% +$3.74K 0.14% 46
2026
Q1
$368K Buy
13,101
+2,415
+23% +$64.3K 0.18% 41
2025
Q4
$266K Sell
10,686
-856
-7% -$21.6K 0.13% 54
2025
Q3
$294K Buy
11,542
+634
+6% +$15.6K 0.15% 49
2025
Q2
$264K Sell
10,908
-61
-0.6% -$1.42K 0.14% 52
2025
Q1
$278K Buy
10,969
+406
+4% +$10.6K 0.16% 54
2024
Q4
$280K Sell
10,563
-173
-2% -$4.69K 0.16% 51
2024
Q3
$311K Buy
10,736
+1,075
+11% +$31.4K 0.18% 47
2024
Q2
$270K Sell
9,661
-59
-0.6% -$1.62K 0.17% 50
2024
Q1
$270K Sell
9,720
-1,120
-10% -$31.1K 0.17% 50
2023
Q4
$312K Buy
10,840
+886
+9% +$26.8K 0.22% 46
2023
Q3
$330K Sell
9,954
-2,079
-17% -$73.5K 0.27% 42
2023
Q2
$441K Sell
12,033
-366
-3% -$14.2K 0.35% 35
2023
Q1
$506K Buy
12,399
+66
+0.5% +$2.85K 0.43% 34
2022
Q4
$632K Sell
12,333
-65
-0.5% -$3.12K 0.55% 25
2022
Q3
$543K Buy
12,398
+73
+0.6% +$3.55K 0.5% 26
2022
Q2
$646K Sell
12,325
-419
-3% -$21.4K 0.6% 23
2022
Q1
$660K Sell
12,744
-1,880
-13% -$97.5K 0.59% 26
2021
Q4
$864K Buy
+14,624
New +$725K 0.76% 24

Other funds holding PFE

CarsonAllaria Wealth Management's PFE Position: Q2 2026 in Review

CarsonAllaria Wealth Management increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $3.74K and bringing the position to 13,244 shares worth $319K. The position accounts for 0.14% of the portfolio, ranked #46.

CarsonAllaria Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $864K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • CarsonAllaria Wealth Management held 13,244 shares of Pfizer worth $319K as of Q2 2026.
  • CarsonAllaria Wealth Management bought 143 Pfizer shares in Q2 2026, an estimated $3.74K.
  • Pfizer made up 0.14% of CarsonAllaria Wealth Management's portfolio in Q2 2026, its #46 holding.
  • CarsonAllaria Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • CarsonAllaria Wealth Management's Pfizer position peaked at $864K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on CarsonAllaria Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.